Pennsylvania high schools are mandated to stock naloxone, the opioid-reversing medication, under new legislation.
In a significant move aimed at addressing the opioid crisis, Pennsylvania lawmakers have introduced legislation that mandates all high schools in the state to carry naloxone, a life-saving drug that can reverse opioid overdoses. The proposal, brought forth by State Senators Christine Tartaglione and Nikil Saval, seeks to equip every public and private high school—regardless of its location—with this critical resource.
Originally inspired by the Forum for Legislative Action at the University of Pennsylvania, a student advocacy group that has witnessed the devastating rise of the fentanyl crisis, this initiative underscores the urgency felt by young people driven to take action. The group has expressed its belief that equipping schools with naloxone is essential for empowering students and staff with “lifesaving tools.” Advocates argue that by ensuring wider access to this drug in educational settings, Pennsylvania can take a proactive approach to safeguarding its youth and confronting this continuing public health emergency.
While Pennsylvania has allowed schools to store naloxone since 2015, this legislation would be a significant advancement, positioning the state among a select few that mandate the availability of the drug in schools. Notably, neighboring New Jersey has also implemented similar requirements as part of its response efforts to the opioid epidemic.
Importantly, though schools would be required to stock naloxone, the legislation does not obligate all staff to participate in emergency responses. Instead, it designates “opioid emergency responders” who would voluntarily undergo training to administer the drug when necessary, thereby respecting the wishes of employees who may not feel comfortable acting in such a critical situation.
Senator Tartaglione, who has been in recovery from alcohol addiction for over twenty years, emphasizes the personal significance of this legislation, underscoring that even one saved life due to the availability of naloxone would justify the effort. Senator Saval echoed this sentiment, suggesting that building secure communities where individuals struggling with addiction can find support is critical.
While the path forward for this legislation is not guaranteed, it will undergo evaluation by a Senate committee before a vote can take place in the full Senate. Both senators express optimism that the bill could pass in the current legislative session, citing a shared commitment across political lines to address the opioid crisis and support recovery efforts.
